Inzymes ApS

Private limited companyCVR 44272113GentofteActive

Inzymes ApS is a private limited company, based in Gentofte, active in manufacture of other food products n.e.c., founded in 2023. Equity was negative at the end of 2025 (−DKK 184k). The company made a loss in both 2024 and 2025, most recently DKK 1.5m.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 1.1m+79.5% vs. 2024
Net profit−DKK 1.5m+79.8% vs. 2024
Equity−DKK 184k−101.9% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 7.2m to DKK 1.5m (2024 → 2025).
  • Equity turned negative: −DKK 184k (2024 → 2025).

Employees

  • 1 more employees than a year earlier: 4 (07/2026) against 3 (07/2025).

Registrations, last 24 months

  • 27/03/2026: Moved to Sandtoften 10, 2820 Gentofte

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2023–2025 · amounts in DKK thousand

Equity and net profit

−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15m202320242025
EquityNet profit
Financial figures for Inzymes ApS
202320242025Change
Revenuenot statednot statednot stated–
Gross profit−4,618−5,297−1,085+79.5%
Operating profit (EBIT)−5,813−10,519−1,751+83.4%
Profit before tax−5,794−10,137−1,768+82.6%
Net profit−5,794−7,167−1,451+79.8%
Total assets16,80810,491930−91.1%
Equity16,6199,452−184−101.9%
Liabilities1891,0391,114+7.3%
Cash and cash equivalents16,7317,401604−91.8%
Average number of employees3330%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 6m−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2m202320242025
Gross profitMedian, the industry (81 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 184k at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 3 years in a row

    Net result has been negative in 2023–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

3 financial years
Annual reports for Inzymes ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/05/2025The companyPDFXBRL
202301/09/2023 – 31/12/202308/04/2024The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123409/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

81 companies in the database

Comparison with the other companies in manufacture of other food products n.e.c. based on the latest financial year.

Gross profit−DKK 1.1mNo. 76 of 81
Better than 6% of the companies in the industry
Equity−DKK 184kNo. 67 of 81
Better than 18% of the companies in the industry
Number of employees4No. 51 of 81
Better than 38% of the companies in the industry

Industry median: gross profit DKK 1.5m, net profit DKK 27,940, equity DKK 757k, 6 employees.

DKK 100kDKK 932kDKK 8.7mDKK 81mDKK 358.9m
Distribution of gross profit for 62 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,817of 69,742
Better than 1%
No. 63,458of 69,964
Better than 9%
Same industry and fewer than 20 employees64 companies in the comparison
No. 60of 64
Better than 6%
No. 50of 64
Better than 22%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,315of 16,614
Better than 2%
No. 14,465of 16,661
Better than 13%
All companies of type ApS66,508 companies in the comparison
No. 65,660of 66,379
Better than 1%
No. 59,839of 66,505
Better than 10%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of other food products n.e.c.
Gross profit
  1. Inzymes ApS−DKK 1.1m
  2. Fertin Pharma A/SDKK 755.3m
  3. CP Kelco ApSDKK 561.7m
Net profit
  1. Inzymes ApS−DKK 1.5m
  2. Fertin Pharma A/S−DKK 280.8m
  3. CP Kelco ApSDKK 87m
Equity
  1. Inzymes ApS−DKK 184k
  2. Fertin Pharma A/SDKK 1.3bn
  3. CP Kelco ApSDKK 2.5bn
Employees
  1. Inzymes ApS4
  2. Fertin Pharma A/S949
  3. CP Kelco ApS368

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • HJM Holding ApS25%
  • Sacco S.r.l.66.67%
Inzymes ApS

Management

8 active registrations

Executive management

Executive management at Inzymes ApS
NameRoleAppointed
Michael Fooken JensenDirector01/09/2023
Johannes Maarten van den BrinkDirector30/09/2023
Jonas JacobsenDirector20/12/2023

Board of directors

Board of directors at Inzymes ApS
NameRoleAppointed
Johannes Maarten van den BrinkBoard member30/09/2023
Michael Fooken JensenBoard member30/09/2023
Carlo AppenniniChair of the board30/09/2023
Iris VergaBoard member30/09/2023
Viola VergaBoard member30/09/2023
Founders
HJM Holding ApS

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.

Address and production units

1 active production units

Sandtoften 10
2820 Gentofte

Gentofte Municipality · Postcode 2820

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
INZYMES ApSSandtoften 10, 2820 Gentofte61029598637

Purpose

Selskabets formål er udvikling, produktion og salg af ingredienser til fødevarer samt anden dermed efter direktionens skøn beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

19 registered events
20262 changesaccounts 1 · address 1
  • Annual report for 2025 published
  • Moved to Sandtoften 10, 2820 Gentofte
20251 changeaccounts 1
  • Annual report for 2024 published
20242 changesaddress 1 · accounts 1
  • Moved to Strandvejen 125, 2900 Hellerup
  • Annual report for 2023 published
202314 changesmanagement 8 · capital 1 · ownership 4 · founded 1
  • Jonas Jacobsen appointed director
  • Share capital changed from 40,000 DKK to 133,333 DKK
  • Johannes Maarten van den Brink appointed director
  • Johannes Maarten van den Brink appointed board member
  • Michael Fooken Jensen appointed board member
  • Iris Verga appointed board member
  • Viola Verga appointed board member
  • Carlo Appennini appointed chair of the board
  • HJM Holding ApS registered as owner (25%)
  • SACCO S.R.L. registered as owner (66.67%)
  • HJM Holding ApS is no longer registered as owner
  • Registered as INZYMES ApS
  • Michael Fooken Jensen appointed director
  • HJM Holding ApS registered as owner (100%)

Related companies

Same industry in Gentofte

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction